Related references
Note: Only part of the references are listed.Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts
Tat-San Lau et al.
JOURNAL OF PATHOLOGY (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
Jeffrey L. Wong et al.
CANCER RESEARCH (2013)
Dynamics of T-cell infiltration during the course of ovarian cancer: The gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells
Anna Fialova et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
Nikos G. Gavalas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer
Baoyao Xue et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors
Martyna Szpakowska et al.
BIOCHEMICAL PHARMACOLOGY (2012)
CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
Nassima Redjimi et al.
CANCER RESEARCH (2012)
Angiogenesis: A promising therapeutic target for ovarian cancer
A. Bamias et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Molecular Mechanisms of Pancreatic Cancer Dissemination: The Role of the Chemokine System
Federica Marchesi et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Chemokine Receptor Antagonists
James Pease et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Fractalkine Receptor CX(3)CR1 Is Expressed in Epithelial Ovarian Carcinoma Cells and Required for Motility and Adhesion to Peritoneal Mesothelial Cells
Mijung Kim et al.
MOLECULAR CANCER RESEARCH (2012)
The Lymphotactin Receptor Is Expressed in Epithelial Ovarian Carcinoma and Contributes to Cell Migration and Proliferation
Mijung Kim et al.
MOLECULAR CANCER RESEARCH (2012)
Revisiting the Complexity of the Ovarian Cancer Microenvironment-Clinical Implications for Treatment Strategies
Natasha Musrap et al.
MOLECULAR CANCER RESEARCH (2012)
Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium
K. M. Archibald et al.
ONCOGENE (2012)
Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression
Xiu-Jie Sheng et al.
ONCOLOGY REPORTS (2012)
Targeting chemokine receptors in chronic inflammatory diseases: An extensive review
Pim J. Koelink et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Autocrine CCL5 Signaling Promotes Invasion and Migration of CD133+Ovarian Cancer Stem-Like Cells via NF-?B-Mediated MMP-9 Upregulation
Haixia Long et al.
STEM CELLS (2012)
In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis
Rachel A. Davidowitz et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Tumor immune surveillance and ovarian cancer Lessons on immune mediated tumor rejection or tolerance
Lana E. Kandalaft et al.
CANCER AND METASTASIS REVIEWS (2011)
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
Elda Righi et al.
CANCER RESEARCH (2011)
PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
Natasa Obermajer et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The role of chemokines and their receptors in angiogenesis
Friedemann Kiefer et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Chemokines in health and disease
Dayanidhi Raman et al.
EXPERIMENTAL CELL RESEARCH (2011)
Immunity and immune suppression in human ovarian cancer
Claudia C. Preston et al.
IMMUNOTHERAPY (2011)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
Identification of the Chemokine CX3CL1 as a New Regulator of Malignant Cell Proliferation in Epithelial Ovarian Cancer
Francoise Gaudin et al.
PLOS ONE (2011)
Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium
Marcin P. Iwanicki et al.
CANCER DISCOVERY (2011)
Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma
Li Guo et al.
Chinese Journal of Cancer (2011)
Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
Isaiah G. Schauer et al.
NEOPLASIA (2011)
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Thomas J. Schall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion
Nami Miyanishi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy
Anika Agarwal et al.
CANCER RESEARCH (2010)
CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis
Gong Yang et al.
CLINICAL CANCER RESEARCH (2010)
Ovarian cancer creates a suppressive microenvironment to escape immune elimination
Refika Yigit et al.
GYNECOLOGIC ONCOLOGY (2010)
Microenvironmental Regulation of Chemokine (C-X-C- Motif) Receptor 4 in Ovarian Carcinoma
Maria V. Barbolina et al.
MOLECULAR CANCER RESEARCH (2010)
FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation
Michael Brave et al.
ONCOLOGY (2010)
LIM and SH3 Protein-1 Modulates CXCR2-Mediated Cell Migration
Dayanidhi Raman et al.
PLOS ONE (2010)
Ovarian Cancer
Kathleen R. Cho et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
Erik De Clercq
BIOCHEMICAL PHARMACOLOGY (2009)
CCL5-Mediated Endogenous Antitumor Immunity Elicited by Adoptively Transferred Lymphocytes and Dendritic Cell Depletion
Yolanda Nesbeth et al.
CANCER RESEARCH (2009)
VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis
Nicole F. Neel et al.
JOURNAL OF CELL SCIENCE (2009)
An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells
Joseph Kwong et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Phenotypic and Functional Delineation of Murine CX3CR1+ Monocyte-Derived Cells in Ovarian Cancer
Kevin M. Hart et al.
NEOPLASIA (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Maraviroc: The first of a new class of antiretroviral agents
Rodger D. MacArthur et al.
CLINICAL INFECTIOUS DISEASES (2008)
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
William M. Merritt et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Involvement of SDF-1 alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma
Hiroaki Kajiyama et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells
Zhigang Guo et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2007)
Seven transmembrane receptors: something old, something new
R. J. Lefkowitz
ACTA PHYSIOLOGICA (2007)
Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs) - Role in the inflammatory response within tumors
Ramin Lotfi et al.
JOURNAL OF IMMUNOTHERAPY (2007)
The chemokine network: A target in cancer biology?
Violet I. F. Slettenaar et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse
Thora K. Bjarnadottir et al.
GENOMICS (2006)
Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer
Anna E. Lokshin et al.
GYNECOLOGIC ONCOLOGY (2006)
Dimerization of chemokine receptors and its functional consequences
JY Springael et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
The inflammatory cytokine tumor necrosis factor-α regulates chemokine receptor expression on ovarian cancer cells
H Kulbe et al.
CANCER RESEARCH (2005)
The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
K Balabanian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Stromal cell-derived factor-1α (SDF-lα/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation
C Porcile et al.
EXPERIMENTAL CELL RESEARCH (2005)
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma
S Wei et al.
CANCER RESEARCH (2005)
International Union of Pharmacology. XLVI. G protein-coupled receptor list
SM Foord et al.
PHARMACOLOGICAL REVIEWS (2005)
The repertoire of G-protein-coupled receptors in fully sequenced genomes
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2005)
Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level
IV Nesmelova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers
KM Burleson et al.
GYNECOLOGIC ONCOLOGY (2004)
Heterodimerization and cross-desensitization between the μ-opioid receptor and the chemokine CCR5 receptor
CG Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers
KM Burleson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Tumour necrosis factor α:: a potential target for the therapy of solid tumours
PW Szlosarek et al.
LANCET ONCOLOGY (2003)
Immunologic principles and immunotherapeutic approaches in ovarian cancer
KL Knutson et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2003)
The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
WP Zou et al.
NATURE MEDICINE (2001)
Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
M Mellado et al.
EMBO JOURNAL (2001)
Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells
R Salcedo et al.
FASEB JOURNAL (2000)
The strategy of blocking the chemokine system to combat disease
AEI Proudfoot et al.
IMMUNOLOGICAL REVIEWS (2000)
Thrombin signalling and protease-activated receptors
SR Coughlin
NATURE (2000)
Regulatory T cells: Key controllers of immunologic self-tolerance
S Sakaguchi
CELL (2000)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma
A Sica et al.
JOURNAL OF IMMUNOLOGY (2000)
CD44 and beta 1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins
RC Casey et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)
Share Paper
